BCAL DIAGNOSTICS LIMITED

ASX: BDX

Sector: Sector:Health Care
Industry group: Industry:Pharmaceuticals, Biotechnology & Life Sciences

Latest BDX ASX Announcements

6 Aug 2026 · 7:34 pmPresentations
Bioshares Conference Investor Presentation
6 Aug 20267:34 pmBioshares Conference Investor PresentationPresentations
30 July 2026 · 6:38 pmQuarterly Reports
Quarterly Activities/Appendix 4C Cash Flow Report
30 July 20266:38 pmQuarterly Activities/Appendix 4C Cash Flow ReportQuarterly Reports
15 July 2026 · 4:51 amOther
Notification regarding unquoted securities - BDX
15 July 20264:51 amNotification regarding unquoted securities - BDXOther
15 July 2026 · 4:44 amOther
Notification regarding unquoted securities - BDX
15 July 20264:44 amNotification regarding unquoted securities - BDXOther
15 July 2026 · 4:32 amOther
Notification regarding unquoted securities - BDX
15 July 20264:32 amNotification regarding unquoted securities - BDXOther
15 July 2026 · 4:20 amOther
Notification regarding unquoted securities - BDX
15 July 20264:20 amNotification regarding unquoted securities - BDXOther
3 July 2026 · 3:13 amOther
Becoming a substantial holder for GSS
3 July 20263:13 amBecoming a substantial holder for GSSOther
2 July 2026 · 8:04 pmCompany Update
BCAL to Acquire Shares in Genetic Signatures
2 July 20268:04 pmBCAL to Acquire Shares in Genetic SignaturesCompany Update
29 June 2026 · 7:57 pmPeriodic Reports
BCAL Secures Funding for FY2027
29 June 20267:57 pmBCAL Secures Funding for FY2027Periodic Reports
18 June 2026 · 7:52 pmCompany Update
BCAL Develops New Blood Test for Breast Cancer Recurrence
18 June 20267:52 pmBCAL Develops New Blood Test for Breast Cancer RecurrenceCompany Update
28 May 2026 · 6:25 pmCompany Update
Validation Agreement Signed with Sonic USA, for Breastest V2
28 May 20266:25 pmValidation Agreement Signed with Sonic USA, for Breastest V2Company Update
19 May 2026 · 8:09 pmCompany Update
BCAL Launches Early Detection Cancer Platform
19 May 20268:09 pmBCAL Launches Early Detection Cancer PlatformCompany Update
11 May 2026 · 6:23 pmOther
BCAL Appoints Anne-Louise Arnett as Chief Executive Officer
11 May 20266:23 pmBCAL Appoints Anne-Louise Arnett as Chief Executive OfficerOther
22 Apr 2026 · 6:50 pmQuarterly Reports
Quarterly Activities/Appendix 4C Cash Flow Report
22 Apr 20266:50 pmQuarterly Activities/Appendix 4C Cash Flow ReportQuarterly Reports
31 Mar 2026 · 8:11 pmCompany Update
BCAL Submits MSAC Application for Avantect Pancreatic Test
31 Mar 20268:11 pmBCAL Submits MSAC Application for Avantect Pancreatic TestCompany Update

View complete BDX announcement history →